Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

CME Test Questions, Exercises of Credit and Risk Management

Examples of CME Test Questions and Case Studies.

Typology: Exercises

2021/2022

Uploaded on 02/24/2022

eknath
eknath 🇺🇸

4.7

(29)

266 documents

1 / 4

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Examples of CME Test Questions and Case Studies
CME Test Questions:
CME Test questions are meant to test the knowledge of the attendee or online learner. The questions should
focus on the most important aspects of the presentation rather than on details at the periphery. The questions
should be difficult for someone who did not attend the presentation but easy for anyone who attended. The
questions should follow the format and style below. Please be clear and concise. Questions should have five
options of answers of a through e. One of your questions may also be True or False. Please clearly mark the
correct answer and explain why it is correct. See two examples below.
Example 1:
Presentation: Genetics: Shaping Our Understanding of Addiction and Its Treatment
1-1. All of the following statements about drug development are true EXCEPT (choose one):
(a) Promising medications may be taken out of development unnecessarily
(b) The current regulatory environment encourages risk-taking
(c) The current market environment is not conducive to developing “me too” types of medications
(d) There has been a shift in corporate culture at pharmaceutical companies; today, scientists often are
not in critical decision-making positions
(e) None of the above
1-2. Based on a paper published in Science (Paul et al., 2010), the highest cost of drug development is
associated with (choose one):
(a) anesthetics/analgesics
(b) cardiovascular agents
(c) anti-infective agents
(d) neuropsychiatric agents
(e) antiobesity agents
1-3. For a drug to be approved for the treatment of substance use disorder, the FDA may require (choose
one):
(a) A success/failure analysis
(b) An analysis based on group means
(c) A reduction in drug use, although not necessarily abstinence
(d) Inclusion of a compliance measure
(e) None of the above
Example 2:
Presentation: Use and Abuse of Prescription Opioids: Current Evidence
2-1. According to the National Survey on Drug Use and Health, which of the following best describes the
magnitude of the number of individuals who have used any prescription opioid illicitly, compared with
those who have used heroin in their lifetime (choose one):
(a) Nonmedical use of prescription opioids is two times greater than heroin use
(b) Nonmedical use of prescription opioids is half the volume of heroin use
(c) Nonmedical use of prescription opioids is 10 times greater than heroin use
(d) Nonmedical use of prescription opioids is one-tenth the volume of heroin use
pf3
pf4

Partial preview of the text

Download CME Test Questions and more Exercises Credit and Risk Management in PDF only on Docsity!

Examples of CME Test Questions and Case Studies

CME Test Questions: CME Test questions are meant to test the knowledge of the attendee or online learner. The questions should focus on the most important aspects of the presentation rather than on details at the periphery. The questions should be difficult for someone who did not attend the presentation but easy for anyone who attended. The questions should follow the format and style below. Please be clear and concise. Questions should have five options of answers of a through e. One of your questions may also be “True or False”. Please clearly mark the correct answer and explain why it is correct. See two examples below.

Example 1: Presentation: Genetics: Shaping Our Understanding of Addiction and Its Treatment

1-1. All of the following statements about drug development are true EXCEPT (choose one): (a) Promising medications may be taken out of development unnecessarily (b) The current regulatory environment encourages risk-taking (c) The current market environment is not conducive to developing “me too” types of medications (d) There has been a shift in corporate culture at pharmaceutical companies; today, scientists often are not in critical decision-making positions (e) None of the above

1-2. Based on a paper published in Science (Paul et al., 2010), the highest cost of drug development is associated with (choose one): (a) anesthetics/analgesics (b) cardiovascular agents (c) anti-infective agents (d) neuropsychiatric agents (e) antiobesity agents

1-3. For a drug to be approved for the treatment of substance use disorder, the FDA may require (choose one): (a) A success/failure analysis (b) An analysis based on group means (c) A reduction in drug use, although not necessarily abstinence (d) Inclusion of a compliance measure (e) None of the above

Example 2: Presentation: Use and Abuse of Prescription Opioids: Current Evidence

2-1. According to the National Survey on Drug Use and Health, which of the following best describes the magnitude of the number of individuals who have used any prescription opioid illicitly, compared with those who have used heroin in their lifetime (choose one): (a) Nonmedical use of prescription opioids is two times greater than heroin use (b) Nonmedical use of prescription opioids is half the volume of heroin use (c) Nonmedical use of prescription opioids is 10 times greater than heroin use (d) Nonmedical use of prescription opioids is one-tenth the volume of heroin use

(e) Overall, nonmedical use of prescription opioids and heroin are comparable in volume

2-2. The number of emergency department visits related to misuse and abuse of prescription opioids has surpassed the number of ED visits for which of the following drugs (choose one): (a) Cocaine (b) Methamphetamine (c) Marijuana (d) Methadone (e) All of the above

2-3. All of the following areas are addressed in the Administration's 2011 Prescription Drug Abuse Prevention Plan EXCEPT (choose one): (a) Education of providers (b) Education of patients (c) Enhanced law enforcement (d) Prescription monitoring programs (e) Tamper-resistant formulations

Case Studies: Case studies help illustrate real world situations where the knowledge presented in the course will be applied. Cases studies can be used to illustrate a typical situation that attendees of the presentation will definitely come across. Case studies can also be used to illustrate an extraordinary case that attendees might struggle with if they came across it in a real world situation. Case studies should reinforce the key aspects of the presentation rather than the details. Please give a detailed description of how the case presents itself, a FAKE name for any persons in the case, and one or two questions per case with five options (a through e). Please also provide the correct answer and an explanation as to why it is correct. Don’t give any real names, photos, or other real personal information. Feel free to get creative. See two examples below:

Example 1: Presentation: ER/LA Opioid REMS – Case: Eleanor Eleanor: History

  • 56 year-old Caucasian female with fibromyalgia, degenerative disc disease with chronic back pain
  • Treated with opioids in the past (Oxycontin 80mg bid, oxycodone 15mg 6x/day, zolpidem 10mg has, alprazolam 1mg bid, sertralline 100mg daily).
  • No history of early refills, nonsmoker, chronic depression and anxiety.
  • 5-Q SOAPP score is 2 (no illegal drug use, nonsmoker, no legal hx or meds over prescribed amounts)
  • ORT score is 2 (no family or personal history of substance abuse, >45yo, + history of sexual abuse and psych disease)
  • Complains of severe pain, and wants to restart medications as previously.
  • Issues to explore:
    • Benefit vs. harm?
    • Opioid trial?
    • No use of sedative/hypnotics?
    • Proper treatment of psych issues?
    • History of treatment for sexual trauma?
    • Exercise, nutrition, sleep hygiene, counseling support, family involvement. Question: Which of the following would be an important first step prior to starting any new medication? A. Obtain a comprehensive urine toxicological screen
  • If she cannot safeguard her medications, you will consider an alternative therapy
  • You will not provide early renewal of prescription again
  • At the next visit
  • UDT positive for hydromorphone (negative other drugs)
  • Anne reports she
  • Purchased a medication safe that same day
  • Counts her medication daily
  • Spoke to her sister RE concerns about her niece/nephews